Text Size Normal Text Sizing Button Medium Text Sizing Button Large Text Sizing Button Text Contrast Normal Contrast Button Reverse Contrast Button Switch to Spanish Language Press Room Contact Us Sitemap Sign In Register
Link to Homepage About BrightFocus
BrightFocus
Donate Now Get Involved  
Alzheimer's Disease Research Macular Degeneration Research National Glaucoma Research


Sign up for Email Notifications
If you would like to be notified when funding or meeting opportunities are announced please click on the link below.

Sign up for new announcements.

Please add ResearchGrants@BrightFocus.org to your institution’s white list to insure that the notification is not blocked by your organization’s SPAM filters.

This email list is not sold or distributed, and serves only as an annual reminder of the availability of research support through the BrightFocus Foundation (www.brightfocus.org). Please follow instructions on the notification emails for removal requests.

 
 
BrightFocus Research Grants Funding
Grant Funding for Alzheimer's Research
Grant Funding for Macular Degeneration Research
Grant Funding for Glaucoma Research
 

 

Alzheimer's Disease Research
Completed Award

Gunner Gouras, M.D.

Columbia
New York, NY

Title: Mechanism of Abeta accumulation induced synaptic dysfunction in AD
Non-Technical Title:

Duration: April 1, 2005 - March 31, 2007
Award Type: Standard
Award Amount: $300,000

Details:

Dr. Gouras is looking to better understand how accumulation of beta-amyloid within nerve cells may lead to the characteristic synaptic dysfunction and degeneration of nerve cell processes that occur in Alzheimer’s disease. Recent evidence has indicated that the transport of the precursor of beta-amyloid is important in the disease process, and that nerve cell activity promotes beta-amyloid secretion. Given that accumulation of beta-amyloid may be quite important for the development of the disease, Dr. Gouras’ experiments plan to elucidate the biological mechanism by which synaptic activity alters beta-amyloid, and to better define how beta-amyloid accumulation within nerve cells may be involved in the disease. The ultimate aim of this experiment is to help in devising novel therapies for Alzheimer’s disease.